ATLAS CAPITAL ADVISORS LLC – Eli Lilly and Company Transaction History
ATLAS CAPITAL ADVISORS LLC portfolio value:
$1.21M
portfolio value
ATLAS CAPITAL ADVISORS LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.33% | 121 shares | 35.92K | $323.35 | 3.75K |
| Q2 2022 | share | Decrease | -19.71% | -893 shares | -118.03K | $324.23 | 3.63K |
| Q1 2022 | share | Increase | +83.48% | 2.06K shares | 615.26K | $286.37 | 4.53K |
| Q4 2021 | share | Decrease | -58.41% | -3.46K shares | -689.75K | $277.25 | 2.46K |
| Q3 2021 | share | Increase | +5448.60% | 5.83K shares | 1.34M | $230.3 | 5.93K |
| Q2 2021 | share | Increase | +64.62% | 42 shares | 12.41K | $228.04 | 107 |
| Q1 2021 | share | Increase | 0.00% | 65 shares | 12.14K | $184.81 | 65 |